Company Information

CIN
Status
Date of Incorporation
16 May 2005
Listing Status
Unlisted
State
Hyderabad
ROC
ROC Hyderabad
Industry
Pharmaceutical And Botanical Products
Sub Category
Subsidiary of Foreign Company
Last Balance Sheet
31 March 2023
Last Annual Meeting
28 September 2023
Paid Up Capital
293,907,500
Authorised Capital
300,000,000
Financials All Documents available from MCA @Rs 199/-

Past Directors

Jonathan Zalevsky
Jonathan Zalevsky
Director
over 5 years ago
Kevin John Brodbeck
Kevin John Brodbeck
Director
over 5 years ago
Mark Andrew Wilson
Mark Andrew Wilson
Director
almost 6 years ago
Gilbert Mercier Labrucherie Jr
Gilbert Mercier Labrucherie Jr
Director
over 9 years ago
Ramesh Panchagnula
Ramesh Panchagnula
Whole Time Director
over 9 years ago
Jillian B Thomsen
Jillian B Thomsen
Additional Director
about 10 years ago
Maninder Singh Hora
Maninder Singh Hora
Director
over 13 years ago
Stephen Kohl Doberstein
Stephen Kohl Doberstein
Director
over 13 years ago
Raman Narasinham Akella
Raman Narasinham Akella
Whole Time Director
over 16 years ago

Registered Trademarks

Nektar Nektar Therapeutics

[Class : 5] Pharmaceutical Preparations Having Enhanced Drug Performance And/Or Drug Delivery Performance For The Treatment And/Or Prophylaxis Of Diseases Or Medical Conditions Such As Diabetes, Infections, Cancers And Inflammations, Or Of Diseases Or Medical Conditions That Affect The Peripheral Nerves, The Adrenergic And/Or Cholinergic Receptors, The Histamine Receptors, T...

Nektar Nektar Therapeutics

[Class : 1] Chemicals Relating To Drug Performance And Or Drug Delivery Performance For Research Use And Manufacturing In The Biotechnical, Biomedical And Pharmaceutical Industries.

Documents

XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-31122020
Form AOC-4(XBRL)-31122020
Form MGT-6-20032020_signed
-20032020
Form MGT-7-02012020_signed
List of share holders, debenture holders;-31122019
Copy of MGT-8-31122019
Form DIR-12-17112019_signed
Form AOC-4(XBRL)-17112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-23102019
Optional Attachment-(2)-24072019
Notice of resignation;-24072019
Form DIR-12-24072019_signed
Evidence of cessation;-24072019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24072019
Optional Attachment-(1)-24072019
Form ADT-1-19042019_signed
Copy of the intimation sent by company-19042019
Optional Attachment-(1)-19042019
Copy of resolution passed by the company-19042019
Copy of written consent given by auditor-19042019
Form DIR-11-19042019_signed
Form DIR-12-19042019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-18042019
Evidence of cessation;-18042019
Acknowledgement received from company-18042019
Proof of dispatch-18042019
Notice of resignation filed with the company-18042019
Optional Attachment-(1)-18042019
Notice of resignation;-18042019